Abivax

NCT02452242

Safety, PK and PD Study of ABX464 in Untreated HIV Patients

NCT02735863

ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment

NCT03093259

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

NCT03368118

Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis

NCT03813199

Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis

NCT03760003

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

NCT04049448

Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis

NCT04023396

Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis

NCT05177835

Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

NCT06456593

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease